BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

357 related articles for article (PubMed ID: 10354606)

  • 1. Acetylcholine in mind: a neurotransmitter correlate of consciousness?
    Perry E; Walker M; Grace J; Perry R
    Trends Neurosci; 1999 Jun; 22(6):273-80. PubMed ID: 10354606
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acetylcholine and hallucinations: disease-related compared to drug-induced alterations in human consciousness.
    Perry EK; Perry RH
    Brain Cogn; 1995 Aug; 28(3):240-58. PubMed ID: 8546852
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathology and neurotransmitter abnormalities of dementia with Lewy bodies.
    Duda JE
    Dement Geriatr Cogn Disord; 2004; 17 Suppl 1():3-14. PubMed ID: 14676464
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Central cholinergic dysfunction measured "in vivo" correlates with different behavioral disorders in Alzheimer's disease and dementia with Lewy body.
    Marra C; Quaranta D; Profice P; Pilato F; Capone F; Iodice F; Di Lazzaro V; Gainotti G
    Brain Stimul; 2012 Oct; 5(4):533-8. PubMed ID: 22019082
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic approaches to cholinergic deficiency in Lewy body diseases.
    Barrett MJ; Cloud LJ; Shah H; Holloway KL
    Expert Rev Neurother; 2020 Jan; 20(1):41-53. PubMed ID: 31577469
    [No Abstract]   [Full Text] [Related]  

  • 6. Involvement of alpha6/alpha3 neuronal nicotinic acetylcholine receptors in neuropsychiatric features of Dementia with Lewy bodies: [(125)I]-alpha-conotoxin MII binding in the thalamus and striatum.
    Ray M; Bohr I; McIntosh JM; Ballard C; McKeith I; Chalon S; Guilloteau D; Perry R; Perry E; Court JA; Piggott M
    Neurosci Lett; 2004 Dec; 372(3):220-5. PubMed ID: 15542244
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Selective stimulations and lesions of the rat brain nuclei as the models for research of the human sleep pathology mechanisms].
    Šaponjić J
    Glas Srp Akad Nauka Med; 2011; (51):85-97. PubMed ID: 22165729
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reappraising neurotransmitter-based strategies.
    Möller HJ
    Eur Neuropsychopharmacol; 1999 Apr; 9 Suppl 2():S53-9. PubMed ID: 10332935
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A genetic rat model of cholinergic hypersensitivity: implications for chemical intolerance, chronic fatigue, and asthma.
    Overstreet DH; Djuric V
    Ann N Y Acad Sci; 2001 Mar; 933():92-102. PubMed ID: 12000038
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nicotinic acetylcholine receptors and nicotinic cholinergic mechanisms of the central nervous system.
    Dani JA; Bertrand D
    Annu Rev Pharmacol Toxicol; 2007; 47():699-729. PubMed ID: 17009926
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacologic therapy of dementia with Lewy bodies.
    Kaufer DI
    J Geriatr Psychiatry Neurol; 2002; 15(4):224-32. PubMed ID: 12489919
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Muscarinic and nicotinic responses in the developing pedunculopontine nucleus (PPN).
    Good CH; Bay KD; Buchanan R; Skinner RD; Garcia-Rill E
    Brain Res; 2007 Jan; 1129(1):147-55. PubMed ID: 17156760
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beyond Acetylcholinesterase Inhibitors: Novel Cholinergic Treatments for Alzheimer's Disease.
    Kamkwalala AR; Newhouse PA
    Curr Alzheimer Res; 2017; 14(4):377-392. PubMed ID: 27697062
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Rapid-eye-movement sleep disorders in Parkinson's disease].
    Gagnon JF; Montplaisir J; Bédard MA
    Rev Neurol (Paris); 2002 Feb; 158(2):135-52. PubMed ID: 11965170
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distribution of m1 muscarinic acetylcholine receptors in the hippocampus of patients with Alzheimer's disease and dementia with Lewy bodies-an immunohistochemical study.
    Shiozaki K; Iseki E; Hino H; Kosaka K
    J Neurol Sci; 2001 Dec; 193(1):23-8. PubMed ID: 11718746
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impaired hippocampal acetylcholine release parallels spatial memory deficits in Tg2576 mice subjected to basal forebrain cholinergic degeneration.
    Laursen B; Mørk A; Plath N; Kristiansen U; Bastlund JF
    Brain Res; 2014 Jan; 1543():253-62. PubMed ID: 24231553
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The cognitive psychopharmacology of Alzheimer's disease: focus on cholinergic systems.
    Lawrence AD; Sahakian BJ
    Neurochem Res; 1998 May; 23(5):787-94. PubMed ID: 9566619
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The cholinergic system in aging and neuronal degeneration.
    Schliebs R; Arendt T
    Behav Brain Res; 2011 Aug; 221(2):555-63. PubMed ID: 21145918
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interactions between the amyloid and cholinergic mechanisms in Alzheimer's disease.
    Pákáski M; Kálmán J
    Neurochem Int; 2008 Nov; 53(5):103-11. PubMed ID: 18602955
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thalamic D2 receptors in dementia with Lewy bodies, Parkinson's disease, and Parkinson's disease dementia.
    Piggott MA; Ballard CG; Dickinson HO; McKeith IG; Perry RH; Perry EK
    Int J Neuropsychopharmacol; 2007 Apr; 10(2):231-44. PubMed ID: 16448581
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.